… advanced, non-squamous (NSQ) non-small
cell
lung cancer (NSCLC). Opdivo continued to demonstrate … cell
lung cancer support the potential for this
Immuno-Oncology agent in treating
lung cancer … (5%)
than docetaxel (15%).
About
Lung Cancer
Lung cancer is the leading cause of …
No comments:
Post a Comment